Authors:
JESTICE HK
FARRINGTON M
HUNT C
MATTHEWS I
SCOTT MA
FOREMAN J
MARCUS RE
Citation: Hk. Jestice et al., BACTERIAL-CONTAMINATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR TRANSPLANTATION, TRANSFUSION MEDICINE, 6(2), 1996, pp. 103-110
Citation: M. Schnaidt et al., FREQUENCY AND SPECIFICITY OF PLATELET-SPECIFIC ALLOANTIBODIES IN HLA-IMMUNIZED HEMATOLOGIC-ONCOLOGIC PATIENTS, TRANSFUSION MEDICINE, 6(2), 1996, pp. 111-114
Citation: Bm. Kumpel et Sr. Sooranna, TRANSCYTOSIS OFIGG ANTI-D BY HUMAN TERM TROPHOBLAST CELLS IN CULTURE, TRANSFUSION MEDICINE, 6(2), 1996, pp. 115-120
Citation: Ahc. Chan et al., FROM MAXIMUM SURGICAL BLOOD ORDERING SCHEDULE TO UNLIMITED COMPUTER CROSS-MATCHING - EVOLUTION OF BLOOD-TRANSFUSION FOR SURGICAL PATIENTS AT A TERTIARY HOSPITAL IN HONG-KONG, TRANSFUSION MEDICINE, 6(2), 1996, pp. 121-124
Citation: J. Neppert et Tw. Jungi, ANTIBODIES TO HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX PRODUCTS INHIBITFC-GAMMA RECEPTORS TYPE-I AND TYPE-II, TRANSFUSION MEDICINE, 6(2), 1996, pp. 125-131
Citation: Mt. Murphy et al., DEVELOPMENT OF A PCR-BASED DIAGNOSTIC ASSAY FOR THE DETERMINATION OF KEL GENOTYPE IN DONOR BLOOD-SAMPLES, TRANSFUSION MEDICINE, 6(2), 1996, pp. 133-137
Citation: F. Komatsu et M. Kajiwara, TRANSIENT DEPRESSION OF LW(A) ANTIGEN WITH COINCIDENT PRODUCTION OF ANTI-LW(A) REPEATED IN RELAPSES OF MALIGNANT-LYMPHOMA, TRANSFUSION MEDICINE, 6(2), 1996, pp. 139-143
Citation: Re. Broadberry et M. Lin, THE DISTRIBUTION OF THE MIIII (GP.MUR) PHENOTYPE AMONG THE POPULATIONOF TAIWAN, TRANSFUSION MEDICINE, 6(2), 1996, pp. 145-148
Citation: De. Pegg et R. Parker, STANDARDS FOR TISSUE-BANKING, JUNE 1995 - BRITISH-ASSOCIATION-OF-TISSUE-BANKS, TRANSFUSION MEDICINE, 6(2), 1996, pp. 155-158
Citation: ABSTRACTS OF PAPERS PRESENTED AT THE 29TH ANNUAL SCIENTIFIC MEETING OF THE AUSTRALASIAN-SOCIETY-OF-BLOOD-TRANSFUSION, BRISBANE, AUSTRALIA, 15-18 OCTOBER 1995, TRANSFUSION MEDICINE, 6(2), 1996, pp. 159-170
Citation: ABSTRACTS OF PAPERS PRESENTED AT THE 4TH EUROPEAN SYMPOSIUM ON PLATELET AND GRANULOCYTE IMMUNOBIOLOGY, 18-21 MAY 1996, HAMEENLINNA, FINLAND, TRANSFUSION MEDICINE, 6(2), 1996, pp. 172-208
Citation: G. Whyte et P. Coghlan, COMPARATIVE SAFETY OF UNITS DONATED BY AUTOLOGOUS, DESIGNATED AND ALLOGENEIC (HOMOLOGOUS) DONORS, TRANSFUSION MEDICINE, 6(2), 1996, pp. 209-209
Citation: Mh. Kanter et Ld. Petz, COMPARATIVE SAFETY OF UNITS DONATED BY AUTOLOGOUS, DESIGNATED AND ALLOGENEIC (HOMOLOGOUS) DONORS - COMMENT, TRANSFUSION MEDICINE, 6(2), 1996, pp. 209-211
Authors:
MARCONI M
ALMINI D
PIZZI MN
RICCARDI D
BERGAMASCHI W
GIOVANETTI AM
REBULLA P
SIRCHIA G
Citation: M. Marconi et al., QUALITY ASSURANCE OF CLINICAL TRANSFUSION PRACTICE BY IMPLEMENTATION OF THE PRIVILEGE OF BLOOD PRESCRIPTION AND COMPUTERIZED PROSPECTIVE AUDIT OF BLOOD REQUESTS, TRANSFUSION MEDICINE, 6(1), 1996, pp. 11-19
Citation: Rc. James et De. Matthews, ANALYSIS OF BLOOD-DONOR RETURN BEHAVIOR USING SURVIVAL REGRESSION METHODS, TRANSFUSION MEDICINE, 6(1), 1996, pp. 21-30
Citation: Pl. Harper et al., THE PLASMA TURNOVER OF TRANSFUSED ANTITHROMBIN CONCENTRATE IN PATIENTS WITH ACQUIRED ANTITHROMBIN DEFICIENCY, TRANSFUSION MEDICINE, 6(1), 1996, pp. 45-50
Authors:
HOU M
STOCKELBERG D
RYDBERG L
KUTTI J
WADENVIK H
Citation: M. Hou et al., BLOOD-GROUP A ANTIGEN EXPRESSION IN PLATELETS IS PROMINENTLY ASSOCIATED WITH GLYCOPROTEIN IB AND IIB - EVIDENCE FOR AN A(1) A(2) DIFFERENCE/, TRANSFUSION MEDICINE, 6(1), 1996, pp. 51-59